Lexicon Pharmaceuticals's total assets for Q4 2025 were $184.99M, a decrease of -10.17% from the previous quarter. LXRX total liabilities were $77.45M for the fiscal quarter, a -9.70% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.